Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
SPRC
SciSparc Ltd.
CAPPED RATING
SciSparc Ltd. (SPRC) is rated D+ (1.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Momentum (F).
Quantitative Factor Evaluation • Updated
Overall Rating
1.8
/ 5.0
D+
Value
B
Factor Score
3.4
/ 5.0
Growth
D-
Factor Score
0.9
/ 5.0
Profitability
D+
Factor Score
1.7
/ 5.0
Momentum
F
Factor Score
0.4
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
0.0
EV / EBITDA
-1.2
Rev Growth YoY
-38.4%
Gross Margin
N/M
Price Return 3M
-94.7%
Price Return 12M
-98.6%
Catalyst Signal
0.00
Market Cap
$869.8K
TTM Revenue
$679.0K
Price / Sales
1.3
ROE
-164.5%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B (3.4) | D- (0.9) | D+ (1.7) | F (0.4) | C+ (2.6) | D+ (1.8) |
| 2026-11-08 | B (3.4) | D- (0.9) | D+ (1.7) | D- (0.8) | C+ (2.6) | C- (1.9) |
| 2026-11-01 | B (3.4) | D- (0.9) | D+ (1.8) | F (0.6) | C+ (2.7) | C- (1.9) |
| 2026-10-25 | B (3.3) | D- (0.9) | D+ (1.8) | D- (0.9) | C+ (2.6) | C- (1.9) |
| 2026-10-18 | B (3.2) | D- (0.9) | D+ (1.8) | D (1.3) | C+ (2.6) | C- (1.9) |
Page
1
of
4